Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
Date:8/20/2008

XI'AN, China, Aug. 20 /Xinhua-PRNewswire/ -- Huifeng Bio-Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced it will be in attendance at the CPhI South America Conference, August 19-21 in Rio de Janeiro, Brazil.

"Unparalleled business opportunities for all companies involved in the pharmaceutical raw materials industry are now presenting themselves throughout South America, particularly in Brazil, " stated Jing' An Wang, CEO, Huifeng. "Huifeng is becoming recognized as a leading industry player and has much to offer the South American, as well as to the global, pharmaceutical market."

"We are excited to begin cultivating new relationships with corporations from around the world during this important conference," said Mr. Wang.

According to CPhI, there are more than 180 million people living in Brazil alone. With a rapidly emerging market second only to China and a growth rate exceeding that of the global average, South America continues to promote an attractive business arena.

Due to the rapid amount of global investment taking place in Brazil much is to be gained by establishing new business partnerships with local suppliers, buyers and manufacturers.

About CMP Information and CPhI Pharmaceutical Conferences

CMP Information, part of United Business Media plc, a London Stock Exchange listed media company, is responsible for the organization of the world's leading CPhI, ICSE, Hi and Fi series of pharmaceutical and food ingredient trade shows. CPhI is the leading international exhibition provider in the pharmaceutical ingredients and allied industries markets. This is the first CPhI conference to take place in South America.

About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB.OB)

Huifeng Bio-Pharmaceutical Technology, Inc., located in X
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
2. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
3. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
4. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
5. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
6. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
7. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status
8. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
9. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
10. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
11. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:...advancedlasersystemsandinstrumentsforthestemcellre...tionalandfinancialresultsforthethirdquarterendedSe...1.46millioncomparedwith$1.43millioninQ32008,-Gross...nQ3,2008,-Netlossreducedto$148,000comparedto$283,0...
(Date:11/24/2009)...--HealthRoboticstodayannounced,thatithasformedanew....ThisrecentlyformedToronto-basedcompanywilloperate...t,install,andsupport,HealthRobotics,i.v.RoomoftheF...offeringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,...nan"asneeded,basis"toitsstrategicpartnershipswithM...
(Date:11/23/2009)...vocative new study, a University of Utah scientist...major cause of global warming cannot be stabilize...builds the equivalent of one new nuclear power pla...ll be any substantial near-term departure from rec...sion rates," says the new paper by Tim Garrett, an...
(Date:11/23/2009)...ire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDL...7,2009astheex-dividenddateforits$200millionspecial...ontransactioncompletedonNovember2,2009.Thedividend...rdontherecorddate,December1,2009.NASDAQhassettheap...eofcommonstockforpurposesoftheex-dividenddateonNov...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... , , , , Multiporator / Electr... , , , Transformation... 01/2002 , , , , , ,... Microorganism , Pseudomonas aer...ype , Bacteria, gram negative, ...
... , , , , Multiporator / Electr... , , , Transformatio... 01/2002 , , , , , ,... Microorganism , Nocardia cora...e , Bacteria, gram positive, ,...
... , , , , Multiporator / Electr... , , , Transformatio... 03/2002 , , , , , ,... Microorganism , Mycobacterium... Cell type , Bacteria, gram positive,...
Other Biology Technology:Pseudomonas aeruginosa 2Nocardia corallina 2Mycobacterium smegmatis 2
(Date:11/23/2009)...160 participants gathered this week for the sevent...E conference. This year,s topic, "Synthetic Biolog...dical researchers to explore the engineering, scie... field of synthetic biology. , Bonnie L. Bassler...ersity and this year,s conference chair, challenge...
(Date:11/23/2009)...e vaccine available for the H1N1 virus has been se...us. The vaccination marks the first time vaccine h...ndemic flu., Iowa State University,s Hank Harris...ne this summer and has been shipping preventive do...s for several weeks., The latest vaccines were s...
(Date:11/23/2009)...study by University of Alabama at Birmingham (UAB)...co-existing medical conditions (co-morbidity) do n...frican-Americans compared to Caucasians who also h...v. 23 in Cancer , a journal of the American Cance... BMI and co-morbidity are independent predictors o...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 1Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 3Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 4Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 1Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 3Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 1China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 2China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 3China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 5China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 6China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 7China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 8China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 9China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 10China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 11China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 12China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 13
...p elucidate mechanisms of wake-sleep transitions a...sity of Pennsylvania School of Medicine have demon...called astrocytes are directly involved in regulat...ng of the study is that astrocytes modulate the le...h is thought to be important in controlling wake-t...
...scientists at UCSF sheds light on how the odor det...eir social behavior. , "Understanding how mice pr...tes the sense of smell--should provide insight int... use to transform sensory information into behavio...SF assistant professor of anatomy. , "There are s...
...ldiers guarding a castle gate, multiple genetic de...owdery mildew disease, according to a new study. P...ts that attacks more than 9,000 species, including...tural plants such as roses and cucumbers. The rese...ein of the Carnegie Institution,s Department of Pl...
Other Biology News:Penn study finds direct role for glial cells in brain cross-talk 2New study examines how sense of smell affects mating and aggression in mice 2Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products: